Clinical Trials Logo

Aging clinical trials

View clinical trials related to Aging.

Filter by:

NCT ID: NCT00474279 Completed - Aging Clinical Trials

Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults

MOT089
Start date: July 1998
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether treatment of healthy older men and women with oral MK-677 for 12 months will enhance pulsatile GH release and increase mean GH and IGF-I concentrations into the range of young adults and will have favorable effects on body composition and functional ability on older adults.

NCT ID: NCT00472823 Completed - Aging Clinical Trials

Vitamin D Supplementation in Older Women

VIDOS
Start date: April 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effects of several doses of vitamin D on hormones related to bone, calcium absorption, bone density and muscle strength.

NCT ID: NCT00462722 Completed - Aging Clinical Trials

Myogenic and Osteogenic Responses to eXercise and Ibuprofen

MOXI
Start date: July 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the use of ibuprofen blocks the benefits of exercise to build bone and muscle mass.

NCT ID: NCT00459589 Completed - Cancer Clinical Trials

Nutritional Intervention in Geriatric Oncology

INOGAD
Start date: April 2007
Phase: N/A
Study type: Interventional

Older patients with cancer are poorly treated or not treated at all. A previous study in the south west of France (364 patients) showed that patients receiving chemotherapy had short survival times which strongly depended on nutritional status. In this study, the researchers would like to evaluate if individual dietician follow-up at each cycle of chemotherapy increases survival of patients at risk of undernutrition.

NCT ID: NCT00455741 Completed - Aging Clinical Trials

Postmenopausal Women Estrogen and Progesterone Infusion

Start date: November 2000
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to study the effects of aging, estrogen and progesterone on the brain. Specifically, we want to look at how the hypothalamus and pituitary (two small glands in the brain) respond to estrogen. The pituitary gland is controlled by the hypothalamus. The hypothalamus secretes GnRH (Gonadotropin-Releasing Hormone) that signals the pituitary to secrete the reproductive hormones, LH (Luteinizing Hormone) and FSH (Follicle Stimulating Hormone). These hormones act on the ovaries and signal the ovaries to produce estrogen and progesterone. Estrogen in the bloodstream then acts on the brain to modulate this system with changes in LH and FSH. Early changes associated with low levels of estrogen are inhibitory (estrogen negative feedback) while higher levels of estrogen (such as those present when a follicle in the ovary is ready to ovulate) stimulate LH to cause ovulation (positive feedback). This study will determine: 1) hypothalamic and pituitary levels of glucose uptake (as a measure of brain metabolic activity) at baseline and in association with estrogen negative feedback on LH (24 hr) and estrogen positive feedback on LH (72 hr); and 2) the effect of aging on estrogen feedback on LH, assessing negative feedback (nadir ~ 24 hr) and positive feedback (peak between 72 and 96 hr).

NCT ID: NCT00438347 Completed - Aging Clinical Trials

Influence of Fitness on Brain and Cognition

Start date: April 2006
Phase: N/A
Study type: Observational

The purpose of this study is to examine the effect of aerobic fitness training on human cognition, brain structure, and brain function of older adults.

NCT ID: NCT00435188 Completed - Aging Clinical Trials

Life 2: Improving Fitness and Function in Elders

Project LIFE
Start date: November 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a 12-month physical activity counseling program, compared to usual care, improves physical performance in a sample of older veterans. The primary physical performance outcome is change in gait speed.

NCT ID: NCT00434915 Completed - Aging Clinical Trials

Does DHEA Enhance the Effects of Exercise in Postmenopausal Women?

Start date: April 2003
Phase: N/A
Study type: Interventional

Dehydroepiandrostrone (DHEA) and its sulfated ester (DHEAS) are high circulating weak androgens which have been associated with conditions that accompany age-related decline such as sarcopenia, hyperinsulinemia, osteopenia, and cardiovascular disease. The decline in DHEA with age is particularly marked in postmenopausal women. Exercise has always been advocated in women; benefit has been demonstrated inmuscle, bone and lipid physiology, as well as perception of energy and sense of well-being. This study aims to explore the combined effect of both DHEA and exercise in postmenopausal women, age range 55-75 years old. Subjects will receive DHEA (50mg/day) or placebo for a 12-week period. At the beginning and conclusion of the study patients will undergo testing for muscle strength, body composition, VO2 max, insulin sensitivity, muscle biopsy with mitochondria enzyme measurements, and psychological analysis. Blood samples pre and post intervention will also be obtained and the level of selected anabolic markers, lipids, and androgenic and sex steroid levels will be assessed. For the twelve-week period, both placebo and DHEA treated participants will be involved in a resistance and aerobic exercise program coordinated through the GCRC and the Dan Abraham Healthy Living Center. Several correlations have been established with respect to exogenous DHEA administration in postmenopausal women. None have evaluated oral DHEA therapy in the setting resistance and aerobic exercise, key therapies advocated in postmenopausal women. As a plausible anabolic hormone DHEA is hypothesized to accentuate the effects of exercise as has been shown for testosterone. This study, as a randomized double-blind placebo controlled trial, will investigate the effects, if any, of a regimented exercise program and DHEA supplementation in postmenopausal women, specifically for evidence of enhancement of exercise effect by oral supplementation with DHEA in attenuating age-related decline

NCT ID: NCT00434863 Completed - Aging Clinical Trials

Comparative Study of the Effect of Dysport and Botox

Start date: October 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to test the effect of Dysport and Botox on forehead wrinkles and EMG activity.

NCT ID: NCT00430976 Completed - Aging Clinical Trials

Exercise, Executive Processes and the Aging Brain

Start date: December 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the effect of aerobic exercise on the brain and cognition through the measurement of neuroelectric and behavioral indices of executive control cognitive function in older adults.